| 書(shū)目名稱(chēng) | Cancer Policy: Pharmaceutical Safety |
| 編輯 | June M. McKoy,Dennis P. West |
| 視頻video | http://file.papertrans.cn/222/221175/221175.mp4 |
| 概述 | Describes the latest thoughts and findings relating to drug safety in the cancer domain.Covers emerging strategies to identify adverse drug reactions and drug-drug interactions.Highlights policies ins |
| 叢書(shū)名稱(chēng) | Cancer Treatment and Research |
| 圖書(shū)封面 |  |
| 描述 | Cancer Policy: Pharmaceutical Safety provides invaluable information on the interesting and compelling field of cancer drug safety. Identifying and understanding high-priority policy issues and key pharmacovigilance strategies is of paramount importance. In this volume, outstanding and original chapters provide an overview and synthesis of the latest thoughts and findings relating to drug safety in the cancer domain. Topics include natural language processing and pharmacovigilance of alternative cancer pharmaceuticals. The information presented in this volume will improve understanding of emerging strategies to identify adverse drug reactions and drug-drug interactions within the cancer setting and will highlight policies that have been instituted to improve cancer patient safety. In summary, Cancer Policy: Pharmaceutical Safety explores many of the important areas of pharmacovigilance research in oncology. |
| 出版日期 | Book 2019 |
| 關(guān)鍵詞 | Drug Safety; Health; Oncology; Pharmaceutical; Policy; Toxicity |
| 版次 | 1 |
| doi | https://doi.org/10.1007/978-3-319-43896-2 |
| isbn_ebook | 978-3-319-43896-2Series ISSN 0927-3042 Series E-ISSN 2509-8497 |
| issn_series | 0927-3042 |
| copyright | Springer Nature Switzerland AG 2019 |
|Archiver|手機(jī)版|小黑屋|
派博傳思國(guó)際
( 京公網(wǎng)安備110108008328)
GMT+8, 2025-10-16 07:10
發(fā)表于 2025-3-21 19:27:19
